Hosted by the NeuroGenomics and Informatics Center (NGI)

Short bio: Dr. Maria J Arranz is the Head of the Research Laboratory Unit at the Fundació Mútua Terrassa since 2011. Previously Dr. Arranz conducted psychiatric genetic research at the Institute of Psychiatry, London (1993-2011) and genetic research into xenobiotics (1987-1992, Medical Research Council – Toxicology Unit, London). Dr. Arranz’s work on the pharmacogenetics of antipsychotics is well known, having published leading papers on the use of pharmacogenetics for the prediction of response to antipsychotic treatment. Currently, Dr. Arranz leads several genomic and pharmacogenomic projects in psychiatry, oncology and immunology and has received grant funds to conduct genomic and epigenomic studies of complex disorders and treatment response, and to introduce Artificial intelligence to predict and prevent self-harm and suicide in vulnerable patients . In 2019 Dr. Arranz opened the FMT Pharmacogenetics Unit (FPU) to conduct pharmacogenomic research and to facilitate the access to genetic tests to hospitals and clinical centres. The FPU was one of the first Spanish units to routinely perform tests for users of the child and adolescent psychiatric ward on admission and for treatment-resistant adult patients. Dr. Arranz also lectures in Pharmacogenetics and Pharmacogenomics in several graduate and undergraduate courses.

For inquiries contact the NGI Center.